Press Releases
Prostate Cancer
-
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting
LUND, SWEDEN and PARIS -- (Marketwire) -- 05/18/12 -- Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: IPN; ADR: IPSEY) will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO...
-
Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer
Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer PR Newswire LUNGevity, Nation's Largest Lung Cancer-focused Nonprofit, Funds Critical, Encouraging Research WASHINGTON , May 17, 2012 /PRNewswire-USNewswire/...
-
Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer
Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer -- Results from Phase 1 clinical trial of EP-100 to be presented at ASCO -- PR Newswire...
-
Long Island Capital Alliance and Brookhaven National Laboratory Announce Technology Transfer Capital Forum on June 8, 2012
Presenters and Panelists Selected for First Event Under New Alliance The Long Island Capital Alliance ("LICA"), the leading non-profit capital formation and business development organization serving regional companies, today announced...
-
US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA Multiple Studies Relating to HIFU and Focal Therapy Being Presented at AUA Demonstrate Growing Interest in the Potential of the Minimally Invasive...
-
Northwest Bio Provides Update On DCVax®-L Brain Cancer Trial
Northwest Bio Provides Update On DCVax®-L Brain Cancer Trial Amendment Accepted By FDA, Enhancing and Upgrading the Trial 41 US Clinical Trial Sites Now In Operation PR Newswire BETHESDA, Md. , May 17, 2012 /PRNewswire/ -- Northwest...
-
Prostate Cancer? Why Radical Surgery/Robotic Prostatectomy is NOT For You
Prostate Cancer? Why Radical Surgery/Robotic Prostatectomy is NOT For You PR Newswire CORAL SPRINGS, Fla. , May 17, 2012 /PRNewswire/ -- As the world's top urologists begin the 107th Annual AUA Meeting in Atlanta this Friday, one...
-
Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting
Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting PR Newswire REDWOOD CITY, Calif. , May 16, 2012...
-
Full Breadth and Depth of Accuray's Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31
Full Breadth and Depth of Accuray's Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31 PR Newswire SUNNYVALE, California , May 16, 2012 /PRNewswire/ -- Conference Presentations Highlighted Benefits of...
-
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research PR Newswire Additional $10.5 million approved in FY2013 Department of Defense Lung Cancer Research Program for...
-
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012 -- First data from Phase III trial for regorafenib in gastrointestinal stromal tumor (GIST) presented...
-
Global Human Vaccines Industry
Global Human Vaccines Industry PR Newswire NEW YORK , May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and...
-
New Equation in Prostate Cancer Diagnosis Yields Best Answer Yet
Three Key Factors May Drastically Improve How We Diagnose Prostate Cancer, Paving the Way for More Personalized Prostate Cancer Treatments World-renowned prostate surgeon, Dr. David Samadi, may soon have the equation he needs to strengthen...
-
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015) PR Newswire NEW YORK , May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its...
-
Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic First Patient Enrolled in Second Cohort, Additional Clinical Results Expected in Q3...
Follow us
What people say
Our Partners
© 2005-2012